CRIPPA, STEFANO
 Distribuzione geografica
Continente #
AS - Asia 5.228
NA - Nord America 3.692
EU - Europa 2.750
SA - Sud America 1.330
AF - Africa 99
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.116
Nazione #
US - Stati Uniti d'America 3.499
SG - Singapore 2.271
CN - Cina 1.429
BR - Brasile 1.114
HK - Hong Kong 755
SE - Svezia 723
IT - Italia 536
VN - Vietnam 376
RO - Romania 273
DE - Germania 267
RU - Federazione Russa 261
GB - Regno Unito 156
FI - Finlandia 155
IN - India 110
CA - Canada 103
AR - Argentina 86
FR - Francia 69
MX - Messico 66
PL - Polonia 64
IE - Irlanda 51
BD - Bangladesh 50
JP - Giappone 49
NL - Olanda 47
AT - Austria 40
ZA - Sudafrica 40
ES - Italia 38
ID - Indonesia 35
CO - Colombia 31
EC - Ecuador 31
IQ - Iraq 28
LT - Lituania 24
PY - Paraguay 21
TR - Turchia 21
CL - Cile 18
EG - Egitto 15
MA - Marocco 15
PK - Pakistan 13
UA - Ucraina 12
UY - Uruguay 12
UZ - Uzbekistan 11
VE - Venezuela 11
BE - Belgio 10
IR - Iran 10
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
IL - Israele 8
KE - Kenya 6
NP - Nepal 6
RS - Serbia 6
DZ - Algeria 5
KG - Kirghizistan 5
PE - Perù 5
SA - Arabia Saudita 5
EU - Europa 4
GE - Georgia 4
JM - Giamaica 4
KW - Kuwait 4
TW - Taiwan 4
AL - Albania 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
PH - Filippine 3
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
Totale 13.108
Città #
Singapore 1.013
Hong Kong 748
Dallas 740
Ashburn 522
Shanghai 363
Hefei 296
Beijing 211
New York 207
Lawrence 191
Princeton 191
Milan 166
Los Angeles 150
Ho Chi Minh City 149
São Paulo 123
Boardman 103
Munich 88
Helsinki 80
Moscow 79
Hanoi 69
Nuremberg 60
London 56
Denver 54
Warsaw 48
Dublin 47
Montreal 45
Rome 43
Santa Clara 43
Turku 43
Tokyo 42
Poplar 41
Rio de Janeiro 40
Orem 38
Brooklyn 35
Chennai 34
Stockholm 34
Pune 33
Frankfurt am Main 32
Atlanta 31
Cesano Boscone 31
Chicago 31
The Dalles 30
Belo Horizonte 29
Johannesburg 29
Lappeenranta 29
Guangzhou 28
Phoenix 26
Washington 26
Amsterdam 23
Houston 22
Mexico City 22
Seattle 22
Boston 21
Brasília 21
San Francisco 19
Columbus 18
Toronto 18
Biên Hòa 17
Brescia 17
Campinas 17
Vienna 17
Council Bluffs 16
Porto Alegre 16
Manchester 14
Dhaka 13
Guarulhos 13
Querétaro 13
Thái Bình 13
Assago 12
Hangzhou 12
Ankara 11
Da Nang 11
Montevideo 11
New Delhi 11
Quito 11
Salvador 11
Baghdad 10
Curitiba 10
Falkenstein 10
Jiaxing 10
Tashkent 10
Brussels 9
Fortaleza 9
Haiphong 9
Hải Dương 9
Jakarta 9
Joinville 9
Pisa 9
San Jose 9
Santiago 9
Shenzhen 9
São Bernardo do Campo 9
Tianjin 9
Al Mansurah 8
Cape Town 8
Charlotte 8
City of London 8
Ottawa 8
Asunción 7
Bắc Giang 7
Calgary 7
Totale 7.208
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 322
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 114
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 110
A multimodality test to guide the management of patients with a pancreatic cyst 99
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 95
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 93
A preoperative score to predict early death after pancreatic cancer resection 90
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 90
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 89
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 88
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 87
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 84
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 82
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX 81
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 81
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 76
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 76
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 76
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 76
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 75
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 75
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 75
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 74
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 74
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 72
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 72
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 71
THE VALUE OF (18)FLUOR-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (18FDG-PET/CT) IN RESECTABLE PANCREATIC CANCER: A PROSPECTIVE STUDY 71
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 71
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 71
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 71
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 70
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 70
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 70
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 69
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 68
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 68
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 67
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 67
The impact of preoperative anemia on pancreatic resection outcomes 67
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 67
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 67
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 66
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 66
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 66
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 66
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies 66
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 66
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 65
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 65
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 64
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 63
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 63
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 63
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 63
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 63
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 62
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 61
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 61
Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system 61
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 61
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 60
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 60
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer 60
Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy 59
Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3) 59
Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma 59
The impact of minimally invasive surgery on hospital readmissions, emergency department visits and functional recovery after distal pancreatectomy 59
Prediction of early distant recurrence in upfront resectable pancreatic adenocarcinoma: A multidisciplinary, machine learning-based approach 59
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 58
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 58
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 58
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 58
A grading system can predict clinical and economic outcomes of pancreatic fistula after pancreaticoduodenectomy: results in 755 consecutive patients. 58
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 57
Mesoangioblasts at 20: From the embryonic aorta to the patient bed 57
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 57
Validation of the PROMIS-29 Questionnaire as a Measure of Recovery After Pancreatic Surgery 56
Surgical Planning for “Borderline Resectable” and “Locally Advanced” Pancreatic Cancer During Open Pancreatic Resection 56
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 56
Consensus guidelines on severe acute pancreatitis 56
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 56
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy 55
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 55
Endoscopic ultrasound-guided gastrojejunostomy does not prevent pancreaticoduodenectomy after long-term symptom-free neoadjuvant treatment 54
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 54
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 53
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 53
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 53
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 53
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 53
Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis 53
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 53
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 52
Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy 52
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 52
Acute pancreatitis at the beginning of the 21st century: the state of the art. 52
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting 52
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 52
Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients. Preliminary report 52
Totale 6.911
Categoria #
all - tutte 101.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 30 6 1 2 0 0 0
2021/2022110 0 0 6 50 7 3 7 5 8 12 4 8
2022/20231.296 451 269 96 6 12 169 88 98 58 7 13 29
2023/20241.090 33 41 110 137 107 221 24 113 21 38 83 162
2024/20254.446 474 96 129 157 182 346 837 395 693 452 298 387
2025/20266.433 1.001 1.079 890 1.996 1.151 316 0 0 0 0 0 0
Totale 13.467